TCL Archive Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster” By Cancer History Project May 6, 2011
TCL Archive I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers By Cancer History Project May 6, 2011
TCL Archive FDA Approves Afinitor For pNET; No Word On Sutent For Same Use By Cancer History Project May 6, 2011
TCL Archive The President’s Cancer Panel publishes its annual report By Cancer History Project May 6, 2011
TCL Archive Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable By Cancer History Project April 29, 2011
TCL Archive IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds By Cancer History Project April 29, 2011
TCL Archive Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent By Cancer History Project April 29, 2011
TCL Archive Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting By Cancer History Project April 29, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
